Publizoom

Award notice Supplies

26Far019 b)suministro de medicamentos "exclusivos" (i)

Notice published in Spanish. The AI analysis summarises it for you in your language.

Public buyer
CONSORCIO CORPORACIÓ SANITÀRIA PARC TAULÍ DE SABADELL
Sabadell
Place of performance
Sabadell
Estimated value
€10,074,251 excl. VAT
Amount awarded
€540,765 excl. VAT
Planned end of contract
14 April 2028
likely re-tender around October 2027
Bids received
1
Procedure
Open procedure
Any company may submit a bid.
Publication
19 October 2026
Notice language
Spanish

AI analysis: go for it or not?

Summary in English, criteria, documents to provide and a GO / NO GO verdict in one minute.

Create my free account

Unlimited analyses during the 14-day Pro trial, no card needed.

Description

SUMINISTRO DE MEDICAMENTOS "EXCLUSIVOS" (I)

Awarded to

8 lots

  • ECX224 SUMINISTRO DE MEDICAMENTOS "EXCLUSIVOS" (I)
  • ECX205-216-255 SUMINISTRO DE MEDICAMENTOS "EXCLUSIVOS" (I)
  • ECX236 SUMINISTRO DE MEDICAMENTOS "EXCLUSIVOS" (I)
  • ECX239 SUMINISTRO DE MEDICAMENTOS "EXCLUSIVOS" (I)
  • ECX219 SUMINISTRO DE MEDICAMENTOS "EXCLUSIVOS" (I)
  • ECX209-252 SUMINISTRO DE MEDICAMENTOS "EXCLUSIVOS" (I)
  • ECX208 SUMINISTRO DE MEDICAMENTOS "EXCLUSIVOS" (I)
  • ECX217-225-227 SUMINISTRO DE MEDICAMENTOS "EXCLUSIVOS" (I)

CPV codes

European codes that classify what the contract is about. They are how we find the tenders for your trade.

33600000

Winning prices for comparable contracts

A quarter below
€350,000
Median
€846,164
A quarter above
€2,267,877

Amounts awarded (excl. VAT) over the last 3 years for 265 contracts in the same CPV group (3360…), excluding framework agreements. Half of the contracts fall between the two quartiles. TED source: mostly contracts above the EU thresholds, so amounts tend to be high.

Similar contracts already awarded

ContractWinnerAmount
26Far019 c)suministro de medicamentos "exclusivos" (i)
CONSORCIO CORPORACIÓ SANITÀRIA PARC TAULÍ DE SABADELL · 19 October 2026
LABORATORIOS FARMACEUTICOS ROVI, S.A.
LUNDBECK ESPAÑA, S.A.U.
MENARINI STEMLINE ESPAÑA, S.L.U
Merz Therapeutics Iberia S.L.
PFIZER, S.L.U.
ROCHE FARMA, S.A.
TAKEDA FARMACÉUTICA ESPAÑA S.A.
€808,514
26Far019 a)suministro de medicamentos "exclusivos" (i)
CONSORCIO CORPORACIÓ SANITÀRIA PARC TAULÍ DE SABADELL · 19 October 2026
ABBVIE SPAIN S.L. UNIPERSONAL
ALFASIGMA ESPAÑA S.L
ALMIRALL S.A.
ALNYLAM PHARMACEUTICALS SPAIN SL
AOP ORPHAN PHARMACEUTICALS IBERIA, S.L
ARGENX SPAIN SL
BAXTER, S.L.
AstraZeneca Fca. Spain, S.A.
€1,108,582
Cbam 494/2025 janssen cilag/28
Servicio Andaluz de Salud · 23 October 2026
JANSSEN-CILAG, S.A. €353,000
Suministro de IODIXANOL (VISIPAQUE) E IOHEXOL (OMNIPAQUE) de distribución exclusiva con destino al Servicio de Farmacia del Hospital Clínico San Carlos
HOSPITAL CLINICO SAN CARLOS · 23 October 2026
GE HEALTHCARE BIO-SCIENCES, SAU €505,350
Suministro de Tafasitamab (DOE)
OSAKIDETZA - Servicio Vasco de Salud - Organización Central · 23 October 2026
INCYTE BIOSCIENCES IBERIA, S.L. €2,170,000

Source : TED – Office des publications de l'Union européenne © Union européenne, données retraitées. Reference 722439-2026.